Breaking News Instant updates and real-time market news.

ABMD

Abiomed

$383.61

-27.89 (-6.78%)

04:55
09/06/18
09/06
04:55
09/06/18
04:55

Abiomed management to meet with William Blair

Meetings to be held in Milwaukee on September 5 and in Minneapolis on September 6 hosted by William Blair.

  • 06

    Sep

  • 06

    Nov

ABMD Abiomed
$383.61

-27.89 (-6.78%)

06/22/18
PIPR
06/22/18
NO CHANGE
Target $480
PIPR
Overweight
Abiomed price target raised to $480 from $360 at Piper Jaffray
Piper Jaffray analyst Matt O'Brien raised his price target for Abiomed to $480 after hosting an institutional investor meeting at the company's headquarters. It was another positive meeting as clinicians continue to realize the value of Impella in treating a sick patient population, O'Brien tells investors in a research note. Further, the analyst now believes that Impella Connect should make monitoring patients for the hospital staff much easier in the future. He believes management continues to develop new technologies that should keep Abiomed "well ahead of any future competition." O'Brien does not see a "med tech story that is nearly as compelling as this one." The analyst keeps an Overweight rating on the shares.
07/26/18
PIPR
07/26/18
NO CHANGE
Target $480
PIPR
Overweight
Abiomed post-earnings pullback a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien said the fact that Abiomed raised the low end of guidance but not the high end after its Q1 earnings beat may be "causing some consternation among investors." However, he thinks the momentum in the business is as good as he's seen, pointing to the record employee and surgeon training this quarter as evidence, and would use today's pullback to start or build positions. O'Brien keeps an Overweight rating on Abiomed with a $480 price target.
07/31/18
PIPR
07/31/18
NO CHANGE
PIPR
Overweight
Piper skeptical about Cardiovascular's plans to compete with Abiomed
Cardiovascular Systems (CSII) this morning at its analyst meeting announced it is working on a product to compete with Abiomed's (ABMD) Impella product, Piper Jaffray analyst Matt O'Brien tells investors in a research note. The analyst heard the device is in animals at this point and that Cardiovascular Systems is targeting first-in-man in 2020. While not dismissing another potential Abiomed competitor, O'Brien sees Cardiovascular experiencing the same challenges that the percutaneous heart pump device now owned by Abbott (ABT) has had. As such, he's "skeptical about the timeframe Cardiovascular Systems has laid out and the performance the device will offer." The analyst recommends investors use the recent pullback in Abiomed to start or build positions in the stock. O'Brien has an Overweight rating on the shares with a $480 price target.
08/03/18
PIPR
08/03/18
NO CHANGE
Target $480
PIPR
Overweight
Piper says CMS final reimbursement rule for Impella better than expected
Piper Jaffray analyst Matt O'Brien said the CMS final rule for Impella reimbursement rates is better than expected and "a nice positive" for Abiomed that should ease some investor fears on pricing pressure for the device. He sees the fact that CMS removed a previously proposed cut of 24% to one of the key DRGs - 215 - as the most important piece of information and views the final IPPS as "a nice tailwind" for Abiomed, O'Brien tells investors. He keeps an Overweight rating and $480 price target on the stock.

TODAY'S FREE FLY STORIES

ATU

Actuant

$21.90

-0.15 (-0.68%)

08:07
01/24/19
01/24
08:07
01/24/19
08:07
Hot Stocks
Breaking Hot Stocks news story on Actuant »

Actuant trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRCB

Two River Bancorp

$15.55

-0.06 (-0.38%)

08:06
01/24/19
01/24
08:06
01/24/19
08:06
Hot Stocks
Two River Bancorp announces $2M share repurchase program »

Two River Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKGAY

Merck KGaA

$0.00

(0.00%)

, VRTX

Vertex

$189.93

-3.88 (-2.00%)

08:05
01/24/19
01/24
08:05
01/24/19
08:05
Hot Stocks
Merck KGaA grants license to Vertex for two DNA damage response inhibitors »

Merck KGaA (MKGAY)…

MKGAY

Merck KGaA

$0.00

(0.00%)

VRTX

Vertex

$189.93

-3.88 (-2.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 11

    Feb

08:05
01/24/19
01/24
08:05
01/24/19
08:05
General news
U.S. initial jobless claims preview: »

U.S. initial jobless…

DDAIF

Daimler AG

$0.00

(0.00%)

, PCAR

Paccar

$61.58

-0.48 (-0.77%)

08:04
01/24/19
01/24
08:04
01/24/19
08:04
Hot Stocks
EU commercial vehicle registrations down 4.0% in November »

In December, commercial…

DDAIF

Daimler AG

$0.00

(0.00%)

PCAR

Paccar

$61.58

-0.48 (-0.77%)

CNHI

CNH Industrial

$9.98

-0.06 (-0.60%)

NAV

Navistar

$30.98

-0.33 (-1.05%)

CMI

Cummins

$143.42

-2.69 (-1.84%)

ALSN

Allison Transmission

$47.81

-0.825 (-1.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 05

    Feb

  • 06

    Feb

  • 06

    Feb

FCX

Freeport McMoRan

$12.30

-0.08 (-0.65%)

08:03
01/24/19
01/24
08:03
01/24/19
08:03
Earnings
Freeport McMoRan reports Q4 adj. EPS 11c, consensus 18c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

FLIR

Flir Systems

$44.69

-0.04 (-0.09%)

08:03
01/24/19
01/24
08:03
01/24/19
08:03
Hot Stocks
Flir Systems awarded $39.6M contract for Black Hornet PRS for U.S. Army »

FLIR Systems has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 11

    Mar

  • 12

    Mar

INGR

Ingredion

$98.16

0.27 (0.28%)

08:03
01/24/19
01/24
08:03
01/24/19
08:03
Downgrade
Ingredion rating change  »

Ingredion downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 12

    Feb

  • 18

    Feb

GWW

Grainger

$297.12

-3.29 (-1.10%)

08:03
01/24/19
01/24
08:03
01/24/19
08:03
Earnings
Grainger sees FY19 EPS $17.10-$18.70, consensus $18.07 »

Sees FY19 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 07

    Feb

UNP

Union Pacific

$154.20

-0.8 (-0.52%)

08:02
01/24/19
01/24
08:02
01/24/19
08:02
Hot Stocks
Union Pacific CEO sees FY19 operating margins improving »

"We are optimistic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

GWW

Grainger

$297.12

-3.29 (-1.10%)

08:01
01/24/19
01/24
08:01
01/24/19
08:01
Earnings
Grainger reports Q4 adjusted EPS $3.96, consensus $3.59 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 07

    Feb

UNP

Union Pacific

$154.20

-0.8 (-0.52%)

08:00
01/24/19
01/24
08:00
01/24/19
08:00
Earnings
Union Pacific reports Q4 EPS $2.12, consensus $2.06 »

Reports Q4 revenue $5.8B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

ZEN

Zendesk

$64.38

0.43 (0.67%)

08:00
01/24/19
01/24
08:00
01/24/19
08:00
Initiation
Zendesk initiated  »

Zendesk initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 25

    Feb

QCOM

Qualcomm

$51.73

-2.58 (-4.75%)

08:00
01/24/19
01/24
08:00
01/24/19
08:00
Options
Qualcomm put buyer realizes 153% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

AAPL

Apple

$153.91

0.61 (0.40%)

07:59
01/24/19
01/24
07:59
01/24/19
07:59
Recommendations
Apple analyst commentary  »

Apple consensus estimates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

INCY

Incyte

$75.20

-2.11 (-2.73%)

07:59
01/24/19
01/24
07:59
01/24/19
07:59
Upgrade
Incyte rating change  »

Incyte upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

PGR

Progressive

$65.00

1.82 (2.88%)

07:59
01/24/19
01/24
07:59
01/24/19
07:59
Hot Stocks
Progressive expects to hire over 10,000 people in 2019 »

Progressive expects to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPSN

LivePerson

$21.38

0.7 (3.38%)

07:57
01/24/19
01/24
07:57
01/24/19
07:57
Upgrade
LivePerson rating change  »

LivePerson upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTXS

Citrix

$108.64

0.4 (0.37%)

07:57
01/24/19
01/24
07:57
01/24/19
07:57
Recommendations
Citrix analyst commentary  »

Citrix…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAT

Waters

$229.46

25.94 (12.75%)

07:56
01/24/19
01/24
07:56
01/24/19
07:56
Downgrade
Waters rating change  »

Baird downgrades Waters…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 30

    Jan

SNAP

Snap

$5.98

0.06 (1.01%)

07:55
01/24/19
01/24
07:55
01/24/19
07:55
Recommendations
Snap analyst commentary  »

Snap price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 05

    Feb

  • 03

    Mar

07:55
01/24/19
01/24
07:55
01/24/19
07:55
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

SYF

Synchrony

$29.40

2.85 (10.73%)

, WMT

Walmart

$98.72

1.25 (1.28%)

07:54
01/24/19
01/24
07:54
01/24/19
07:54
Upgrade
Synchrony, Walmart rating change  »

Synchrony upgraded to…

SYF

Synchrony

$29.40

2.85 (10.73%)

WMT

Walmart

$98.72

1.25 (1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 11

    Feb

  • 03

    Mar

  • 28

    May

XLNX

Xilinx

$89.55

-0.89 (-0.98%)

07:54
01/24/19
01/24
07:54
01/24/19
07:54
Recommendations
Xilinx analyst commentary  »

Xilinx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

MEGEF

MEG Energy

07:53
01/24/19
01/24
07:53
01/24/19
07:53
Upgrade
MEG Energy rating change  »

MEG Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.